News Conference News AHA 2016 PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad Michael O'Riordan November 15, 2016
News Conference News AHA 2016 Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study Michael O'Riordan November 14, 2016
News Conference News AHA 2016 Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI Todd Neale November 14, 2016
News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
News Conference News TCT 2016 Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence Todd Neale November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
News Conference News TCT 2016 Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention Yael L. Maxwell November 01, 2016
News Conference News TCT 2016 BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year TCT Daily Staff October 30, 2016
News Conference News TVT 2016 What TAVR Needs Next . . . and What It’s Getting Shelley Wood June 17, 2016
News Conference News SCAI 2016 Operator, Protect Thyself: SCAI Sessions Urge More Self Awareness of Radiation Risks L.A. McKeown May 06, 2016
News Conference News ACC 2016 Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure Todd Neale April 05, 2016
News Conference News ACC 2016 TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough? Shelley Wood April 03, 2016
News Conference News ACC 2016 Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial Yael L. Maxwell April 03, 2016
News Conference News ISET 2016 Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired Michael O'Riordan February 10, 2016
News Conference News ISET 2016 Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk Michael O'Riordan February 09, 2016
News Conference News AHA 2015 DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year Yael L. Maxwell November 09, 2015
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015
News Conference News TCT 2015 BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR Yael L. Maxwell October 15, 2015
News Conference News TCT 2015 RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization Yael L. Maxwell October 13, 2015